Literature DB >> 10612360

Current care of hepatitis C-positive patients by primary care physicians in an integrated delivery system.

D E Nicklin1, C Schultz, C M Brensinger, J P Wilson.   

Abstract

BACKGROUND: Infection with the hepatitis C virus (HCV) is an emerging health problem in the United States. Management of this condition in asymptomatic patients remains controversial.
METHODS: A questionnaire was mailed in November 1997 to all primary care physicians caring for adults (internists and family physicians) in an integrated health delivery system regarding the current approach to screening, diagnosis, and management of HCV infection. Charts of patients whose tests were positive for HCV were audited in selected practice sites to document care received by those patients.
RESULTS: Most physicians (70%) reported ordering alanine aminotransferase (ALT) measurements to screen for HCV infection as part of a complete checkup. Each physician diagnosed an average of 3.1 new cases of HCV infection per year. Patients received widely divergent advice regarding prognosis, precautions to prevent transmission, and treatment. More than one half of the physicians advised their patients that the condition was serious (68%) and to abstain from alcohol (56%) and use condoms in monogamous relationships (62%). In caring for HCV-positive patients, more than three quarters of physicians reported recommending a liver biopsy to patients who had elevated ALT levels, and observing clinically, without liver biopsy, those patients who had normal ALT levels. A chart audit, however, showed less-aggressive intervention. Approximately one third of HCV-positive patients with elevated ALT levels had been seen by a gastroenterologist and had had a liver biopsy. Physicians in practice longer were less likely to recommend treatment with interferon-alpha. Of those patients whose physicians reported they would recommend biopsy and treatment with interferon-alpha, only 36% had a documented liver biopsy in their charts, and 29% had documented interferon-alpha treatment. Only 1.6% and 3.0% of patients, respectively, had received the recommended hepatitis A and hepatitis B vaccines.
CONCLUSIONS: Approaches to screening, diagnosis, and management of HCV infection by primary care physicians vary greatly. There appears to be a considerable population of patients in primary care settings who continue to receive conservative management of asymptomatic HCV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10612360     DOI: 10.3122/jabfm.12.6.427

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  8 in total

Review 1.  A systematic review of provider knowledge of hepatitis C: is it enough for a complex disease?

Authors:  Susan L Zickmund; Kyle E Brown; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

2.  Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity.

Authors:  Stacey B Trooskin; Victor J Navarro; Robert J Winn; David J Axelrod; A Scott McNeal; Maricruz Velez; Steven K Herrine; Simona Rossi
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

3.  Hepatitis C management by addiction medicine physicians: results from a national survey.

Authors:  Alain H Litwin; Hillary V Kunins; Karina M Berg; Alex D Federman; Karyn K Heavner; Marc N Gourevitch; Julia H Arnsten
Journal:  J Subst Abuse Treat       Date:  2007-03-26

4.  Knowledge levels and attitudes of health care professionals toward patients with hepatitis C infection.

Authors:  Farahnaz Joukar; Fariborz Mansour-Ghanaei; Fatemeh Soati; Panah Meskinkhoda
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

Review 5.  Screening in liver disease.

Authors:  Paolo Del Poggio; Marzio Mazzoleni
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

6.  Context of clinical care: the case of hepatitis C in underserved communities--a report from the Primary Care Multiethnic Network (PRIME Net) Consortium.

Authors:  Robert R Leverence; Robert L Williams; Wilson Pace; Bennett Parnes; Yvonne Fry-Johnson; Dorothy R Pathak; Betty Skipper; Elvan Daniels; Philip Kroth
Journal:  J Am Board Fam Med       Date:  2009 Nov-Dec       Impact factor: 2.657

Review 7.  The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries.

Authors:  A Bechini; M Levi; A Falla; A Ahmad; I Veldhuijzen; E Tiscione; P Bonanni
Journal:  J Prev Med Hyg       Date:  2016

Review 8.  HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape.

Authors:  Nancy Reau; Michael W Fried; David R Nelson; Robert S Brown; Gregory T Everson; Stuart C Gordon; Ira M Jacobson; Joseph K Lim; Paul J Pockros; K Rajender Reddy; Kenneth E Sherman
Journal:  Liver Int       Date:  2015-11-22       Impact factor: 5.828

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.